BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun L, Pennells L, Kaptoge S, Nelson CP, Ritchie SC, Abraham G, Arnold M, Bell S, Bolton T, Burgess S, Dudbridge F, Guo Q, Sofianopoulou E, Stevens D, Thompson JR, Butterworth AS, Wood A, Danesh J, Samani NJ, Inouye M, Di Angelantonio E. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses. PLoS Med 2021;18:e1003498. [PMID: 33444330 DOI: 10.1371/journal.pmed.1003498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Kappel DB, Legge SE, Hubbard L, Willcocks IR, O’connell KS, Smith RL, Molden E, Andreassen OA, King A, Jansen J, Helthuis M, Owen MJ, O’donovan MC, Walters JT, Pardiñas AF. Genomic stratification of clozapine prescription patterns using schizophrenia polygenic scores. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.07.014] [Reference Citation Analysis]
2 Castela Forte J, Folkertsma P, Gannamani R, Kumaraswamy S, Mount S, de Koning TJ, van Dam S, Wolffenbuttel BHR. Development and Validation of Decision Rules Models to Stratify Coronary Artery Disease, Diabetes, and Hypertension Risk in Preventive Care: Cohort Study of Returning UK Biobank Participants. J Pers Med 2021;11:1322. [PMID: 34945794 DOI: 10.3390/jpm11121322] [Reference Citation Analysis]
3 Westerlund AM, Hawe JS, Heinig M, Schunkert H. Risk Prediction of Cardiovascular Events by Exploration of Molecular Data with Explainable Artificial Intelligence. Int J Mol Sci 2021;22:10291. [PMID: 34638627 DOI: 10.3390/ijms221910291] [Reference Citation Analysis]
4 Dikilitas O, Schaid DJ, Tcheandjieu C, Clarke SL, Assimes TL, Kullo IJ. Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations. Curr Cardiol Rep 2022. [PMID: 35796859 DOI: 10.1007/s11886-022-01734-0] [Reference Citation Analysis]
5 Abraham G, Rutten-Jacobs L, Inouye M. Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases. Stroke 2021;52:2983-91. [PMID: 34399584 DOI: 10.1161/STROKEAHA.120.032619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ritchie SC, Lambert SA, Arnold M, Teo SM, Lim S, Scepanovic P, Marten J, Zahid S, Chaffin M, Liu Y, Abraham G, Ouwehand WH, Roberts DJ, Watkins NA, Drew BG, Calkin AC, Di Angelantonio E, Soranzo N, Burgess S, Chapman M, Kathiresan S, Khera AV, Danesh J, Butterworth AS, Inouye M. Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases. Nat Metab 2021;3:1476-83. [PMID: 34750571 DOI: 10.1038/s42255-021-00478-5] [Reference Citation Analysis]
7 Widén E, Junna N, Ruotsalainen S, Surakka I, Mars N, Ripatti P, Partanen JJ, Aro J, Mustonen P, Tuomi T, Palotie A, Salomaa V, Kaprio J, Partanen J, Hotakainen K, Pöllänen P, Ripatti S. How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study. Circ Genom Precis Med 2022;15:e003459. [PMID: 35130028 DOI: 10.1161/CIRCGEN.121.003459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Polygenic Risk Score Task Force of the International Common Disease Alliance. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat Med 2021;27:1876-84. [PMID: 34782789 DOI: 10.1038/s41591-021-01549-6] [Reference Citation Analysis]
9 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC Scientific Document Group . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2021:zwab154. [PMID: 34558602 DOI: 10.1093/eurjpc/zwab154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
10 L.j. Visseren F, Mach F, M. Smulders Y, Carballo D, C. Koskinas K, Bäck M, Benetos A, Biffi A, Manuel Boavida J, Capodanno D, Cosyns B, Crawford C, H. Davos C, Desormais I, Di Angelantonio E, H. Franco O, Halvorsen S, Richard Hobbs F, Hollander M, A. Jankowska E, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, P. Tsioufis K, van Dis I, C. van Gelder I, Wanner C, Williams B. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.10.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Moorthie S, Hall A, Babb de Villiers C, Janus J, Brigden T, Blackburn L, Kroese M. How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests? Per Med 2022. [PMID: 35289204 DOI: 10.2217/pme-2021-0148] [Reference Citation Analysis]
12 Dichgans M, Beaufort N, Debette S, Anderson CD. Stroke Genetics: Turning Discoveries into Clinical Applications. Stroke 2021;52:2974-82. [PMID: 34399583 DOI: 10.1161/STROKEAHA.121.032616] [Reference Citation Analysis]
13 Eisenstein M. Ranking the risk of heart disease. Nature 2021;594:S6-7. [DOI: 10.1038/d41586-021-01452-7] [Reference Citation Analysis]
14 Chun M, Clarke R, Cairns BJ, Clifton D, Bennett D, Chen Y, Guo Y, Pei P, Lv J, Yu C, Yang L, Li L, Chen Z, Zhu T; China Kadoorie Biobank Collaborative Group. Stroke risk prediction using machine learning: a prospective cohort study of 0.5 million Chinese adults. J Am Med Inform Assoc 2021;28:1719-27. [PMID: 33969418 DOI: 10.1093/jamia/ocab068] [Reference Citation Analysis]
15 Muse ED, Chen SF, Liu S, Fernandez B, Schrader B, Molparia B, León AN, Lee R, Pubbi N, Mejia N, Ren C, El-Kalliny A, Montes de Oca EP, Aguilar H, Ghoshal A, Dias R, Evans D, Chen KY, Zhang Y, Wineinger NE, Spencer EG, Topol EJ, Torkamani A. Impact of polygenic risk communication: an observational mobile application-based coronary artery disease study. NPJ Digit Med 2022;5:30. [PMID: 35277577 DOI: 10.1038/s41746-022-00578-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Steinfeldt J, Buergel T, Loock L, Kittner P, Ruyoga G, zu Belzen JU, Sasse S, Strangalies H, Christmann L, Hollmann N, Wolf B, Ference B, Deanfield J, Landmesser U, Eils R. Neural network-based integration of polygenic and clinical information: development and validation of a prediction model for 10-year risk of major adverse cardiac events in the UK Biobank cohort. The Lancet Digital Health 2022;4:e84-94. [DOI: 10.1016/s2589-7500(21)00249-1] [Reference Citation Analysis]
17 Moldovan A, Waldman YY, Brandes N, Linial M. Body Mass Index and Birth Weight Improve Polygenic Risk Score for Type 2 Diabetes. J Pers Med 2021;11:582. [PMID: 34205563 DOI: 10.3390/jpm11060582] [Reference Citation Analysis]
18 Lu X, Liu Z, Cui Q, Liu F, Li J, Niu X, Shen C, Hu D, Huang K, Chen J, Xing X, Zhao Y, Lu F, Liu X, Cao J, Chen S, Ma H, Yu L, Wu X, Wu X, Li Y, Zhang H, Mo X, Zhao L, Huang J, Wang L, Wen W, Shu XO, Takeuchi F, Koh WP, Tai ES, Cheng CY, Wong TY, Chang X, Chan MY, Gao W, Zheng H, Chen K, Chen J, He J, Tang CS, Lam KSL, Tse HF, Cheung CYY, Takahashi A, Kubo M, Kato N, Terao C, Kamatani Y, Sham PC, Heng CK, Hu Z, Chen YE, Wu T, Shen H, Willer CJ, Gu D. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J 2022:ehac093. [PMID: 35195259 DOI: 10.1093/eurheartj/ehac093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Rowe IA, D’amico G. Taking a risk-based approach to testing for liver disease in primary care, a step in the right direction. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.038] [Reference Citation Analysis]
20 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies., ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-337. [PMID: 34458905 DOI: 10.1093/eurheartj/ehab484] [Cited by in Crossref: 76] [Cited by in F6Publishing: 26] [Article Influence: 76.0] [Reference Citation Analysis]
21 Wells QS, Bagheri M, Aday AW, Gupta DK, Shaffer CM, Wei WQ, Vaitinadin NS, Khan SS, Greenland P, Wang TJ, Stein CM, Roden DM, Mosley JD. Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults. Circ Genom Precis Med 2021;14:e003341. [PMID: 34463132 DOI: 10.1161/CIRCGEN.121.003341] [Reference Citation Analysis]
22 Collister JA, Liu X, Clifton L. Calculating Polygenic Risk Scores (PRS) in UK Biobank: A Practical Guide for Epidemiologists. Front Genet 2022;13:818574. [DOI: 10.3389/fgene.2022.818574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]